EMPALLO, INC.
Machine learning model that extracts digital biomarkers from clinical data to predict heart failure progression and treatment response
- Sector
- Digital health
- Total capital
- $275K
- Federal grants
- $275K
- 1 award · 2023
- Rank in peer group#10 of 51
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 3 pending · first 2025
- Rank in peer group#3 of 51
Capital timeline
Latest events
- Federal grantNSF · Phase I · SBIR Phase I: Developing Artificial intelligence Models to Predict In-hospital Clinical Trajectories for Heart Failure Patients$275K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 51 peers
Line = medianDigital health · Software
- Federal grants#10 · top 20%
- Granted patents#3 · top 6%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 2 granted of 5- New patentMethods And Systems For Determining Assessments Of Cardiovascular, Metabolic, And Renal Syndromes, Diseases, And DisordersUSPTOUS 12,763,209
- GrantedApparatus And Method For Diagnosing A Medical Condition From A Medical ImageUSPTOUS 12,243,636
- PendingMethods And Systems For Determining Assessments Of Cardiovascular, Metabolic, And Renal Syndromes, Diseases, And DisordersUSPTOApplication 18371284
Show all 5 patent records
- Methods And Systems For Determining Assessments Of Cardiovascular, Metabolic, And Renal Syndromes, Diseases, And DisordersOct 13, 2026 · US 12,763,209Granted
- Apparatus And Method For Diagnosing A Medical Condition From A Medical ImageMar 4, 2025 · US 12,243,636Granted
- Methods And Systems For Determining Assessments Of Cardiovascular, Metabolic, And Renal Syndromes, Diseases, And DisordersMar 28, 2024 · Application 18371284Pending
- Methods And Systems For Assessing Response To Treatment For Cardiovascular, Metabolic, And Renal Syndromes, Diseases, And DisordersApplication 63508312Pending
- Method For Establishing And Using Artificial Neural Network For Patient And Clinical Trial-related Assessment And PredictionApplication 63409107Pending
Related companies, and why
- MONA LABS INC.Similar federal contract value in Digital health · null in contracts
- VitalFlo Inc.Similar federal contract value in Digital health · null in contracts
- BIGFINITE INC.Similar federal contract value in Digital health · null in contracts
- NavHealth, Inc.Similar federal contract value in Digital health · null in contracts
- Human Longevity, Inc.Similar federal contract value in Digital health · null in contracts
- Global Publishing Interactive, Inc.Similar federal contract value in Digital health · null in contracts
Regulatory activity · Digital health
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .